Endo, Penwest sue Impax over painkiller's patent

07/29/2008 | American City Business Journals

Endo Pharmaceuticals Holdings and Penwest Pharmaceuticals filed a patent-infringement suit against Impax Laboratories over its application to make a generic version of the companies' painkiller, Opana ER. The dispute centers on an amendment of Impax's application to include 7.5 mg, 15 mg and 30 mg dosages of the drug.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC